Barricaid was selected as a case study in evaluating strength of evidence for Health Technology Assessments due to its superior clinical outcomes, favorable health economics, and level 1 RCT data.
Read the full article here: https://www.cureus.com/articles/64017-towards-a-more-simplified-approach-for-evaluating-strength-of-evidence-in-health-technology-assessments